News Releases

Leading New Gene-based Therapies

Enochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference


LOS ANGELES, September 13, 2021 (NASDAQ: ENOB) − Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will be making a company presentation to investors at the upcoming H.C. Wainwright Global Life Sciences Conference. Dr. Mark Dybul, CEO will provide an overview of the

Read more

Enochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference

September 13, 2021


Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences’ Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants

August 30, 2021


Distinguished Scientific and Clinical Leader to Join Enochian BioSciences’ Hepatitis B Cure Scientific Advisory Board

August 23, 2021


Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer

July 20, 2021


Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection

July 12, 2021


Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity

June 30, 2021


Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology

June 21, 2021


Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

June 14, 2021


Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure

June 14, 2021


Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy

May 12, 2021


Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy

March 24, 2021


Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference

February 22, 2021